COVID-19 vaccine candidates, the United States set a new record of 300,000 coronavirus deaths. This was a stark reminder that some people cannot wait for a vaccine next spring.The ACTT-2 clinical trial recently investigated the use of both remdesivir and baricitinib, which may help with the recovery of hospitalized COVID-19 patients.
The findings now appear in The New England Journal of Medicine.Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.One reason that COVID-19 is so hard to treat is that it has numerous effects on the body.